mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia

Thomas R. Kozel, William J Murphy, Suzanne Brandt, Bruce R. Blazar, Julie A. Lovchik, Peter Thorkildson, Ann Percival, C. Rick Lyons

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Bacillus anthracis is surrounded by an antiphagocytic polypeptide capsule composed of poly γ-D-glutamic acid (γDPGA). γDPGA has been identified recently as a potential target for vaccine development. Studies of the role of γDPGA in disease have been hampered by the poor Ab response to this antigen and the lack of immunochemical reagents. As a consequence, neither the extent of γDPGA production during anthrax nor the protective activity of γDPGA Abs in inhalation anthrax are known. Here we report production of IgG Abs to γDPGA in mice following an immunization regimen using γDPGA in combination with agonist mAbs to CD40. mAbs were produced that are specific for γDPGA. Passive immunization with γDPGA mAbs protected >90% of mice in a pulmonary model of anthrax that was lethal in control mice (P < 0.0001). Use of γDPGA mAb in an antigen detection immunoassay found that the appearance of γDPGA in serum coincided with the emergence of bacteremia. These studies identify CD40 stimulation as a means for production of Ab and generation of mAbs against a weakly immunogenic antigen and demonstrate that the capsule is an effective target for immunoprotection and for antigen detection in the diagnosis of anthrax.

Original languageEnglish (US)
Pages (from-to)5042-5047
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number14
DOIs
StatePublished - Apr 6 2004
Externally publishedYes

Fingerprint

Bacillus anthracis
Anthrax
Antigens
Capsules
Passive Immunization
Bacteremia
Immunoassay
Glutamic Acid
Immunization
Vaccines
Immunoglobulin G
Lung
Peptides
Serum

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. / Kozel, Thomas R.; Murphy, William J; Brandt, Suzanne; Blazar, Bruce R.; Lovchik, Julie A.; Thorkildson, Peter; Percival, Ann; Lyons, C. Rick.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 14, 06.04.2004, p. 5042-5047.

Research output: Contribution to journalArticle

Kozel, Thomas R. ; Murphy, William J ; Brandt, Suzanne ; Blazar, Bruce R. ; Lovchik, Julie A. ; Thorkildson, Peter ; Percival, Ann ; Lyons, C. Rick. / mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 14. pp. 5042-5047.
@article{99b341ee9ae24e84a0c4b619d614b242,
title = "mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia",
abstract = "Bacillus anthracis is surrounded by an antiphagocytic polypeptide capsule composed of poly γ-D-glutamic acid (γDPGA). γDPGA has been identified recently as a potential target for vaccine development. Studies of the role of γDPGA in disease have been hampered by the poor Ab response to this antigen and the lack of immunochemical reagents. As a consequence, neither the extent of γDPGA production during anthrax nor the protective activity of γDPGA Abs in inhalation anthrax are known. Here we report production of IgG Abs to γDPGA in mice following an immunization regimen using γDPGA in combination with agonist mAbs to CD40. mAbs were produced that are specific for γDPGA. Passive immunization with γDPGA mAbs protected >90{\%} of mice in a pulmonary model of anthrax that was lethal in control mice (P < 0.0001). Use of γDPGA mAb in an antigen detection immunoassay found that the appearance of γDPGA in serum coincided with the emergence of bacteremia. These studies identify CD40 stimulation as a means for production of Ab and generation of mAbs against a weakly immunogenic antigen and demonstrate that the capsule is an effective target for immunoprotection and for antigen detection in the diagnosis of anthrax.",
author = "Kozel, {Thomas R.} and Murphy, {William J} and Suzanne Brandt and Blazar, {Bruce R.} and Lovchik, {Julie A.} and Peter Thorkildson and Ann Percival and Lyons, {C. Rick}",
year = "2004",
month = "4",
day = "6",
doi = "10.1073/pnas.0401351101",
language = "English (US)",
volume = "101",
pages = "5042--5047",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "14",

}

TY - JOUR

T1 - mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia

AU - Kozel, Thomas R.

AU - Murphy, William J

AU - Brandt, Suzanne

AU - Blazar, Bruce R.

AU - Lovchik, Julie A.

AU - Thorkildson, Peter

AU - Percival, Ann

AU - Lyons, C. Rick

PY - 2004/4/6

Y1 - 2004/4/6

N2 - Bacillus anthracis is surrounded by an antiphagocytic polypeptide capsule composed of poly γ-D-glutamic acid (γDPGA). γDPGA has been identified recently as a potential target for vaccine development. Studies of the role of γDPGA in disease have been hampered by the poor Ab response to this antigen and the lack of immunochemical reagents. As a consequence, neither the extent of γDPGA production during anthrax nor the protective activity of γDPGA Abs in inhalation anthrax are known. Here we report production of IgG Abs to γDPGA in mice following an immunization regimen using γDPGA in combination with agonist mAbs to CD40. mAbs were produced that are specific for γDPGA. Passive immunization with γDPGA mAbs protected >90% of mice in a pulmonary model of anthrax that was lethal in control mice (P < 0.0001). Use of γDPGA mAb in an antigen detection immunoassay found that the appearance of γDPGA in serum coincided with the emergence of bacteremia. These studies identify CD40 stimulation as a means for production of Ab and generation of mAbs against a weakly immunogenic antigen and demonstrate that the capsule is an effective target for immunoprotection and for antigen detection in the diagnosis of anthrax.

AB - Bacillus anthracis is surrounded by an antiphagocytic polypeptide capsule composed of poly γ-D-glutamic acid (γDPGA). γDPGA has been identified recently as a potential target for vaccine development. Studies of the role of γDPGA in disease have been hampered by the poor Ab response to this antigen and the lack of immunochemical reagents. As a consequence, neither the extent of γDPGA production during anthrax nor the protective activity of γDPGA Abs in inhalation anthrax are known. Here we report production of IgG Abs to γDPGA in mice following an immunization regimen using γDPGA in combination with agonist mAbs to CD40. mAbs were produced that are specific for γDPGA. Passive immunization with γDPGA mAbs protected >90% of mice in a pulmonary model of anthrax that was lethal in control mice (P < 0.0001). Use of γDPGA mAb in an antigen detection immunoassay found that the appearance of γDPGA in serum coincided with the emergence of bacteremia. These studies identify CD40 stimulation as a means for production of Ab and generation of mAbs against a weakly immunogenic antigen and demonstrate that the capsule is an effective target for immunoprotection and for antigen detection in the diagnosis of anthrax.

UR - http://www.scopus.com/inward/record.url?scp=1842636715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842636715&partnerID=8YFLogxK

U2 - 10.1073/pnas.0401351101

DO - 10.1073/pnas.0401351101

M3 - Article

C2 - 15051894

AN - SCOPUS:1842636715

VL - 101

SP - 5042

EP - 5047

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 14

ER -